CINECA IRIS Institutional Research Information System

TANDOI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4071
EU - Europa 2250
AS - Asia 1345
AF - Africa 72
SA - Sud America 69
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 9
Totale 7848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4017
CN - Cina 902
IT - Italia 524
IE - Irlanda 299
SE - Svezia 288
FR - Francia 212
DE - Germania 182
AT - Austria 158
UA - Ucraina 110
FI - Finlandia 90
GB - Regno Unito 85
VN - Vietnam 72
JP - Giappone 70
KR - Corea 70
BE - Belgio 56
IN - India 56
DK - Danimarca 54
CA - Canada 44
PL - Polonia 44
TR - Turchia 41
TW - Taiwan 39
ES - Italia 31
NL - Olanda 30
AU - Australia 29
BR - Brasile 28
KE - Kenya 21
HK - Hong Kong 19
AR - Argentina 18
CO - Colombia 17
RO - Romania 16
UZ - Uzbekistan 16
RU - Federazione Russa 15
PT - Portogallo 13
CH - Svizzera 11
PH - Filippine 10
ID - Indonesia 9
EU - Europa 8
ZM - Zambia 8
EG - Egitto 7
GR - Grecia 7
MX - Messico 7
IR - Iran 6
PK - Pakistan 6
SD - Sudan 6
TH - Thailandia 6
ZA - Sudafrica 6
CM - Camerun 5
CZ - Repubblica Ceca 5
NO - Norvegia 5
SN - Senegal 5
MN - Mongolia 4
SA - Arabia Saudita 4
SG - Singapore 4
CL - Cile 3
CY - Cipro 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
IQ - Iraq 3
MZ - Mozambico 3
NZ - Nuova Zelanda 3
BF - Burkina Faso 2
BG - Bulgaria 2
CR - Costa Rica 2
GM - Gambi 2
MK - Macedonia 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CU - Cuba 1
EE - Estonia 1
IL - Israele 1
JO - Giordania 1
LU - Lussemburgo 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
Totale 7848
Salva come PNG Salva come JPEG
Città #
Chandler 751
Beijing 431
Ann Arbor 322
Dublin 296
Fairfield 285
Houston 284
Woodbridge 161
Vienna 154
Nyköping 149
Villeurbanne 145
Dearborn 137
Torino 137
Wilmington 133
Redwood City 124
Ashburn 107
Princeton 103
Medford 100
Jacksonville 85
Cambridge 81
Fremont 75
Seattle 59
Guangzhou 53
Shanghai 53
Pisa 50
Turin 42
Brussels 39
Hangzhou 36
Warsaw 34
Dong Ket 33
Nanjing 32
Boston 29
Wuhan 27
Milan 26
Chengdu 19
San Diego 19
Taipei 19
Tokyo 19
Boardman 18
Chongqing 17
Rome 16
Seoul 16
Paris 14
Zhengzhou 14
Central 13
Changchun 13
Hebei 13
London 13
Ottawa 13
San Mateo 13
Melbourne 12
Norwalk 12
Hanoi 11
Hefei 11
Leawood 11
Toronto 11
Kunming 10
Upper Marlboro 9
Berlin 8
Buenos Aires 8
Fuzhou 8
Istanbul 8
Jakarta 8
San Francisco 8
Atlanta 7
Bari 7
Bucharest 7
Jinan 7
Nanchang 7
New Delhi 7
Silver Spring 7
Valdagno 7
Ankara 6
Düsseldorf 6
Guiyang 6
Heidelberg 6
Izmir 6
Jiaxing 6
Los Angeles 6
Malatya 6
Mumbai 6
Málaga 6
Rochester 6
Changsha 5
Friedrichsdorf 5
Madrid 5
Marsciano 5
Nelson 5
Polska 5
Porto 5
Redmond 5
Rotterdam 5
Venezia 5
Villers-la-ville 5
Xian 5
Amsterdam 4
Athens 4
Bangkok 4
Barcelona 4
Bremen 4
Brescia 4
Totale 5163
Salva come PNG Salva come JPEG
Nome #
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 742
Early introduction of subcutaneous hepatitis B immunoglobulin following liver transplantation for hepatitis B virus infection: A prospective, multicenter study 341
Simultaneous Liver-Kidney Transplantation in Adults: A Single-center Experience Comparing Results with Isolated Liver Transplantation 311
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 292
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 237
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication 217
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 209
Liver transplantation for symptomatic centrohepatic biliary cystadenoma 175
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant 171
Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child with CD40 Ligand Deficiency and Cryptosporidium -Induced Liver Cirrhosis 160
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation 154
RANK OF SURVIVAL BENEFIT, AS A PROPOSED PRIORITY SYSTEM, IN LIVER TRANSPLANT WAITING LIST: EVIDENCES FROM AN ITALIAN MULTICENTRE COHORT STUDY 147
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 145
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 137
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 128
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 107
Hypothermic Oxygenated Machine Perfusion of Liver Grafts from Brain-Dead Donors 104
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 103
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 96
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 94
Carbapenemase Producing Klebsiella Pneumoniae Infection in Liver Transplant Recipients: Review of Our Experience 93
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 93
Transplantation of the liver from a HBcAb positive donor into a HCV-RNA positive recipient adversely affects graft survival and worsens the course of HCV recurrence 92
Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study 91
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 91
The effect of D-MELD on graft survival and course of HCV recurrence in HCV-RNA positive recipients after liver transplantation 90
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 90
“U-shaped” mesoportal jump graft to manage portal vein thrombosis during liver transplantation: A case report 88
Serological characterization of occult HBV infection in liver donors 85
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA 85
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma 85
Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection 82
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology 82
Carrying on with liver transplantation during the COVID-19 emergency: Report from Piedmont region 82
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 81
NBAS mutations cause acute liver failure: When acetaminophen is not a culprit 81
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 77
LIVER GRAFT ISCHEMIC PRECONDITIONING: CLINICAL OUTCOMES 3 YEARS AFTER TRANSPLANTATION 76
Peritoneal leukocytoclastic vasculitis as a cause of unexplained persistent ascites after liver transplantation 76
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience 71
HCV infection and HLA-DRB1*11 in liver transplantation: a 15 years marriage 70
ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION 70
DOES CROSSMATCH IMPACT LIVER TRANSPLANTATION OUTCOME? A SINGLE CENTER EXPERIENCE 70
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 69
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity 67
IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS 67
Does the Combination between HCV, Presence of Hepatocarcinoma and MELD Influence the Outcome of Liver Transplantation? 66
Long term follow-up of arterial infrarenal conduit in liver transplantation 64
Combined liver kidney transplantation for primary hyperoxaluria type 1: Will there still be a future? Current transplantation strategies and monocentric experience 64
Mycophenolate monotherapy in Liver Transplantation: Safety and efficacy in 152 patients 62
Two Combined Genetic Markers Identify Hepatitis C Recipients With a Lower Graft Survival From The Earliest Post-Transplant Period 62
USE OF GRAFTS FROM HEPATITIS C VIRUS POSITIVE DONORS IN LIVER TRANSPLANTATION: OUTCOMES UNDER CURRENT SELECTION CRITERIA 62
First UHPLC MS/MS method coupled with automated on-line SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients 62
RELATIONSHIP BETWEEN LIVER GRAFT STEATOSIS, VIRAL RECURRENCE AND POST-LIVER TRANSPLANTATION SURVIVAL IN HEPATITIS C VIRUS POSITIVE RECIPIENTS 61
Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in De-Novo Liver Transplantation 60
Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection 59
HBV cccDNA evaluation in HBV-core antibody (HBcAb)-positive liver transplant donors 59
Prolonged Release Tacrolimus in De-Novo Liver Transplantation: A Single Centre Experience 59
Survey of neonatal respiratory care and surfactant administration in very preterm infants in the Italian Neonatal Network. 59
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? 59
Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy 58
Liver transplantation for hepatitis B with delta coinfection: a single center experience 57
Use of Hepatitis B Core Antibody Positive Donors in Liver Transplantation: Outcomes in HBV Negative Recipients 55
UHPLC-MS/MS Method with On-line SPE to Quantify Tacrolimus and Everolimus in Peripheral Blood Mononuclear Cells: Application of “IS-normalized” Matrix Effect 55
Efficacy and safety profile of Mycophenolate on 1543 liver transplantations 54
SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 54
HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals? 53
Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients 53
Liver transplantation with an uncommon full right hemiliver graft after hydatid cysts resection: Case report and review of the literature 51
Excluded segmental duct bile leakage: the case for bilio-enteric anastomosis 50
Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children 50
Influence of Immunogenetic Donor and Recipient Factors on the Outcome of Liver Transplantation for Hepatits C Virus-Related Chirrosis 49
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease 49
Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen levels in the natural history of chronic HBV infection 48
Differential Intraoperative Effect of Liver Transplant in Different Inborn Errors of Metabolism 46
Liver transplantation for hepatocellular carcinoma within Milan criteria in patients with Model for End-stage Liver Disease score below 15: the impact of the etiology of cirrhosis on long-term survival. 43
Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors 43
A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: a single-center experience 43
Severe Passenger Lymphocyte Syndrome and Acute Rejection in ABO Compatible but non-Identical Liver Transplant Recipient from Hepatitis C Viremic Donor 43
RS12989760 POLYMORPHISM OF INTERLEUKIN 28B AND THE OUTCOME OF LIVER TRANSPLANTATION IN HCV-INFECTED PATIENTS 42
Use of Dual Hypothermic Oxygenated Machine Perfusion to Recover Extended Criteria Pediatric Liver Grafts 38
Evaluation of Graft Fibrosis, Inflammation and Donor-specific Antibodies at Protocol Liver Biopsies in Pediatric Liver Transplant Patients: a Single Center Experience 38
Survey of neonatal respiratory support use in very preterm infants in Italy 33
Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors 32
Three-Dimensional Printing in Pediatric Living Donor Liver Transplantation Planning 30
Quantitation of anti-HBe antibodies in anti-HBc-positive liver donors 28
Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients 26
Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome 7
First report of a gallbladder hemangioma coexisting with gallstones: a case report and literature review of a rare finding 5
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 3
Impact of MELD 30-allocation policy on liver transplant outcomes in Italy 3
Early post-liver transplant use of direct-acting antivirals in naive and NS5A inhibitor-experienced HCV patients 2
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients 2
null 2
Bacterial and Viral Infections in Liver Transplantation: New Insights from Clinical and Surgical Perspectives 1
Totale 8278
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15276
article - articoli 0
book - libri 0
conference - conferenze 5736
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21012
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201838 0000 00 00 00038
2018/2019758 27425041 5545 4678 3312512492
2019/20201372 614448122 107286 145103 12114010194
2020/20211186 105786368 101100 109129 10710491131
2021/20221462 636481100 106125 10798 56122299241
2022/20231969 20619470196 149459 150156 199501400
Totale 8278